
Comorbid ADHD/Depression Treated with Bupropion SR
Abstract
A trial of bupropion sustained release (SR) was conducted in 24 adolescents (ages 11-16 years) with ADHD and either major depressive disorder or dysthymic disorder at the Department of Psychiatry, Dartmouth Medical School, Hanover, NH.
DOI: https://doi.org/10.15844/pedneurbriefs-15-3-9 | Journal eISSN: 2166-6482
Language: English
Page range: 23 - 23
Published on: Mar 1, 2001
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 2001 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.